Research peptide · GH axis research
Ipamorelin
A synthetic pentapeptide with a C-terminal amide, built from the non-standard residue Aib together with His, D-2-naphthylalanine, D-Phe and Lys. It was described in 1998 as a selective growth hormone secretagogue in rat pituitary cell and whole-animal pharmacology.
- Compound type
- Research peptide
- Research area
- GH axis
- Formula
- C38H49N9O5
- Average mass
- 711.853 Da
- Monoisotopic mass
- 711.3857 Da
- Length
- 5 residues
- PubChem
- CID 9831659
What it is
Ipamorelin is a synthetic five-residue peptide with the sequence Aib-His-D-2Nal-D-Phe-Lys-NH2. Its molecular formula is C38H49N9O5 and its average molecular weight is 711.9 g/mol. It carries CAS number 170851-70-4 and PubChem CID 9831659, and is also indexed under the development code NNC 26-0161.
Three of its five positions are not ordinary L-amino acids. The first residue is Aib (2-aminoisobutyric acid), a quaternary alpha-methylated glycine analog; positions three and four are D-2-naphthylalanine and D-phenylalanine. The C-terminus is an amide rather than a free carboxylate. In the pharmacology literature ipamorelin is classified as an agonist at the growth hormone secretagogue receptor, acting through a GHRP-like receptor rather than the growth hormone releasing hormone receptor 1.
Discovery and origin
Ipamorelin was first described and named in 1998 by Raun and colleagues in the Department of GH Biology at Novo Nordisk A/S in Maaloev, Denmark 1. It emerged from a medicinal chemistry program that explored compounds lacking the central Ala-Trp dipeptide of growth hormone releasing peptide 1 (GHRP-1), and it was characterized alongside the earlier peptides GHRP-6 and GHRP-2 as a comparator set 1.
The molecule is fully synthetic. Unlike peptides such as BPC-157 or LL-37, no native protein contains this sequence; the Aib residue and the two D-amino acids do not occur in ribosomally translated proteins.
Structure and chemistry
At 711.9 g/mol and five residues, ipamorelin sits at the small end of the peptide range and behaves in handling terms much like a small organic molecule. The lysine side chain and the histidine imidazole are the ionizable groups; with an amidated C-terminus and no acidic side chains, the molecule carries net positive charge across the usual working pH range, which is what makes the [M+H]+ and [M+2H]2+ series the useful ones in positive-mode mass spectrometry.
The D-2-naphthylalanine residue dominates the molecule's hydrophobic character and gives it strong ultraviolet absorbance, useful for detection during chromatography. Synthetic peptides of this type are isolated as salts, most often acetate or trifluoroacetate. The counter-ion does not shift the observed mass of the peptide ion, but it does mean that a milligram of powder contains less than a milligram of peptide, which matters when preparing gravimetric standards for quantitative work.
How it is studied in the laboratory
The founding characterization paper used primary rat pituitary cell cultures as the in vitro system, measuring growth hormone release into the medium. Ipamorelin gave an EC50 of 1.3 nmol/L with a maximal response of 85 percent relative to GHRP-6, which gave 2.2 nmol/L 1. Receptor assignment was done pharmacologically, by testing the response in the presence of GHRP-type and GHRH-type antagonists; the pattern indicated signaling through a GHRP-like receptor 1.
The same study extended to two animal species. In pentobarbital-anesthetized rats, potency and efficacy for growth hormone release were compared against GHRP-6 by plasma hormone measurement, and in conscious swine the authors measured plasma FSH, LH, prolactin, TSH, ACTH and cortisol alongside growth hormone to assess selectivity across the pituitary hormone panel 1. The paper reported that ACTH and cortisol levels after ipamorelin did not differ significantly from those seen after GHRH stimulation, including at exposures far above the ED50 for growth hormone release 1.
Published non-human work on ipamorelin is thin beyond this founding paper. Most subsequent literature uses the compound as a reference agonist for receptor pharmacology rather than as the object of study.
Analytical notes
Identity is normally confirmed by liquid chromatography coupled to mass spectrometry in positive ion mode. On the average mass of 711.9 g/mol, the expected singly protonated ion falls near m/z 712.91 and the doubly protonated ion near m/z 356.96. Calculations run on the monoisotopic mass of 711.39 instead place [M+H]+ near 712.39, so a certificate should state which convention it uses before a deviation is judged.
Purity is assessed by reversed-phase HPLC with ultraviolet detection, where the naphthylalanine chromophore gives a strong signal. The most informative impurity peaks in a pentapeptide of this composition are deletion sequences and diastereomers arising from epimerization at the D-residues, which coelute closely and reward a shallow gradient. Residual trifluoroacetate from purification can be quantified separately by ion chromatography or fluorine NMR when a counter-ion-free preparation is required.
Storage and handling in the laboratory
As supplied, the material is a lyophilized white powder. It is stored at -20 degrees Celsius, sealed and protected from light. The lyophilized state is hygroscopic, so the sealed vial should be allowed to reach room temperature before it is opened, which keeps atmospheric moisture from condensing onto cold powder. Repeated warming and cooling of the same vial is the handling step most likely to degrade a stored peptide, so aliquoting at first opening is standard practice for laboratories that will return to the material over time.
Open questions in the literature
No experimental structure of ipamorelin bound to its receptor has been published, so the structural basis of the selectivity reported in 1998 remains inferred from pharmacology rather than observed directly. The degree to which the selectivity profile reported in rat and swine preparations translates across other species and cell backgrounds has not been systematically mapped. Quantitative stability data for the amidated C-terminus and the Aib residue under common analytical and storage conditions are also sparse in the public literature.
Identity check
A mass-spectrometry result for Ipamorelin should show peaks near these values. A result more than about one unit away is worth a question to the testing lab. Salt forms such as acetate or TFA do not move these peaks, though they do mean less peptide in each milligram of powder.
| Ion | Expected m/z |
|---|---|
| [M+H]+ | 712.39 |
| [M+2H]2+ | 356.70 |
References
- Raun K, Hansen BS, Johansen NL, Thogersen H, Madsen K, Ankersen M, Andersen PH. Ipamorelin, the first selective growth hormone secretagogue. European Journal of Endocrinology. 1998;139(5):552-561. doi:10.1530/eje.0.1390552. Source
For laboratory research use only. Not for human or animal consumption. Not intended to diagnose, treat, cure, or prevent any disease.
